According to our (Global Info Research) latest study, the global Propofol Medium/Long Chain Fat Emulsion Injection market size was valued at US$ 415 million in 2025 and is forecast to a readjusted size of US$ 530 million by 2032 with a CAGR of 3.6% during review period.
In 2024, global propofol medium/long chain fat emulsion injection production reached approximately 21.65 million units, with an average global market price of around US$ 18 per unit. Propofol is a short-acting, intravenous anesthetic agent used for the induction and maintenance of general anesthesia, sedation for mechanically ventilated adults, and procedural sedation. Propofol has the advantages of fast onset of anesthesia induction, rapid awakening, perfect functional recovery, and low incidence of adverse reactions such as postoperative nausea and vomiting. Propofol medium/long chain fat emulsion injection is an oil-in-water emulsion formulation of propofol, in which the lipid vehicle consists of a mixture of medium-chain triglycerides (MCT) and long-chain triglycerides (LCT), along with an emulsifier (egg lecithin) and glycerol. Its gross profit margin generally ranges from 50% to 80%.
Increasing Demand:
The demand for propofol is increasing, driven by the rising incidence of chronic diseases, surgeries, and medical procedures. The aging population, changing lifestyles, and growing healthcare infrastructure in emerging markets are also contributing to the increasing demand for propofol.
Technological Advancements:
Advances in drug delivery systems and monitoring technologies are enhancing the use of propofol. Innovations such as target-controlled infusion (TCI) systems allow for more precise administration, improving safety and efficacy.
Expanding Applications:
Beyond traditional surgical and diagnostic procedures, propofol’s applications are expanding into areas such as pediatric anesthesia, veterinary medicine, and even in treating certain psychiatric disorders like refractory depression through off-label use.
Intensified Competition:
Competition among manufacturers will intensify further in the coming years. In addition, propofol substitutes will try to occupy more market share.
This report is a detailed and comprehensive analysis for global Propofol Medium/Long Chain Fat Emulsion Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Propofol Medium/Long Chain Fat Emulsion Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Propofol Medium/Long Chain Fat Emulsion Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Propofol Medium/Long Chain Fat Emulsion Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Propofol Medium/Long Chain Fat Emulsion Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Propofol Medium/Long Chain Fat Emulsion Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Propofol Medium/Long Chain Fat Emulsion Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Fresenius Kabi, B. Braun, Guangdong Jiabo Pharmaceutical, Sichuan Biokin Pharmaceutical, Sichuan Kelun Pharmaceutical, Jiangsu Yingke Biopharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Propofol Medium/Long Chain Fat Emulsion Injection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
10 mL
20 mL
50 mL
100 mL
Market segment by Application
Hospital
Clinic
Other
Major players covered
Fresenius Kabi
B. Braun
Guangdong Jiabo Pharmaceutical
Sichuan Biokin Pharmaceutical
Sichuan Kelun Pharmaceutical
Jiangsu Yingke Biopharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Propofol Medium/Long Chain Fat Emulsion Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Propofol Medium/Long Chain Fat Emulsion Injection, with price, sales quantity, revenue, and global market share of Propofol Medium/Long Chain Fat Emulsion Injection from 2021 to 2026.
Chapter 3, the Propofol Medium/Long Chain Fat Emulsion Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Propofol Medium/Long Chain Fat Emulsion Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Propofol Medium/Long Chain Fat Emulsion Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Propofol Medium/Long Chain Fat Emulsion Injection.
Chapter 14 and 15, to describe Propofol Medium/Long Chain Fat Emulsion Injection sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Propofol Medium/Long Chain Fat Emulsion Injection. Industry analysis & Market Report on Propofol Medium/Long Chain Fat Emulsion Injection is a syndicated market report, published as Global Propofol Medium/Long Chain Fat Emulsion Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Propofol Medium/Long Chain Fat Emulsion Injection market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.